QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.60
+1.82% today
Updated 2026-04-30
Market cap
$83.68M
P/E ratio
2.36
P/S ratio
1.56x
EPS (TTM)
$2.42
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
Q32 Bio Inc (QTTB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-8.48M | $6.48M | $-42.56M | $-91.36M | $-94.33M | $-109.75M | $-10.96M | $-18.68M | $-67.72M | $-33.54M |
| Capital expenditures | $1.99M | $1.96M | $24.94M | $21.83M | $3.73M | $2.40M | $2.48M | $5000.00 | $75000.00 | $2000.00 |
| Depreciation | $239797.00 | $684214.00 | $1.29M | $6.32M | $8.90M | $9.54M | $370000.00 | $499000.00 | $487000.00 | — |
| Stock-based comp | — | — | — | — | — | $753000.00 | $1.24M | $1.43M | $4.39M | $2.70M |
| Free cash flow | $-10.47M | $4.52M | $-67.50M | $-113.19M | $-98.06M | $-112.15M | $-13.44M | $-18.68M | $-67.79M | $-33.55M |
| Investing cash flow | $-2.27M | $-81.53M | $-121.79M | $-51.80M | $204.90M | $-50.79M | $-2.47M | $-5000.00 | $19.93M | — |
| Financing cash flow | $378312.00 | $115.23M | $150.99M | $158.21M | $53.09M | $52.17M | $30.07M | $406000.00 | $95.14M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |